Many Patients with Hidradenitis Suppurativa Stop Adalimumab Within a Year
An observational study of US insurance claims found that 60.3 percent of adults with hidradenitis suppurativa discontinued adalimumab during follow-up, ...
An observational study of US insurance claims found that 60.3 percent of adults with hidradenitis suppurativa discontinued adalimumab during follow-up, ...
A 12-month real-world study found galcanezumab patients discontinued preventive treatment less often and reported larger reductions in migraine headache days ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.